Volume 10,Issue 3
Cell therapy for bone fracture repair: A comparative preclinical review of mesenchymal stromal cells from bone marrow and from adipose tissue
Over the last decade, there has been an increasing interest among researchers for human mesenchymal stromal cells (MSC). Their regenerative properties, multilineage differentiation capacity and immunomodulatory properties make them promising candidates for treatment in various conditions. Emerging biotechnology companies specialized in cellular and regenerative therapies have been focusing their interest on MSC-based therapies, and their use in clinical trials has steadily increased. Notably, MSC are currently tested in clinical trials addressing unmet medical needs in the field of bone fracture repair and more specifically in non-union and delayed union fractures where the bone repair process is impaired. Although MSC can be isolated from various tissues, the most commonly studied sources are bone marrow (BM) and adipose tissue (Ad). In this article, we reviewed the literature directly comparing BM- and Ad-MSC for their in vitro characteristics and in vivo osteogenic potential to determine which source of MSC would be more appropriate for bone fracture repair. As considerable variations in experimental settings between studies were found, our review was based on studies meeting specific sets of criteria, notably regarding donors’ age and gender. This review of side-by-side comparisons suggests that while BM-and Ad-MSC share common general characteristics, BM-MSC have a higher intrinsic osteogenic capacity in vitro and bone repair potential in vivo.
1.Friedenstein A J, Petrakova K V, Kurolesova A I, et al. 1968, Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, vol.6(2): 230–247, http://dx.doi.org/10.1097/00007890-196803000-00009
2. Friedenstein A J, Chailakhjan R K and Lalykina K S, 1970, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Proliferation, vol.3(4): 393–403, http://dx.doi.org/10.1111/j.1365-2184.1970.tb00347.x.
3. Ashton B A, Allen T D, Howlett C R, et al. 1980, Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clinical Orthopaedics and Related Research, vol.151: 294–307, http://dx.doi.org/10.1097/00003086-198009000-00040.
4. Bab I, Ashton B A, Gazit D, et al. 1986, Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo. Journal of Cell Science, vol.84: 139–151.
5. Owen M, 1988, Marrow stromal stem cells. Journal of Cell Science, Vol.10(Suppl): 63–76, http://dx.doi.org/10.1242/jcs.1988.Supplement_10.5.
6. Pittenger M F, Mackay A M, Beck S C, et al. 1999, Multilineage potential of adult human mesenchymal stem cells. Science, vol.284(5411): 143–147, http://dx.doi.org/10.1126/science.284.5411.143.
7. Zuk P A, Zhu M, Ashjian P, et al. 2002, Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, vol.13(12): 4279–4295, http://dx.doi.org/10.1091/mbc.E02-02-0105.
8. Dezawa M, Ishikawa H, Itokazu Y, et al. 2005, Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration. Science, vol.309(5732): 314–317, http://dx.doi.org/10.1126/science.1110364.
9. Gang E J, Jeong J A, Hong S H, et al. 2004, Myogenic Differentiation of Mesenchymal Stem Cells Isolated from Human Umbilical Cord Blood. Cell Stem Cell, vol.22(4): 617–624, http://dx.doi.org/10.1634/stemcells.22-4-617.
10. De Bari C, Dell’Accio F, Tylzanowski P, et al. 2001, Multipotent mesenchymal stem cells from adult synovial membrane. Arthritis Rheumatology, vol.44(8): 1928–1942, http://dx.doi.org/10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P.
11. De Bari C, Dell’Accio F, Vandenabeele F, et al. 2003, Skeletal muscle repair by adult mesenchymal stem cells from synovial membrane. The Journal of Cell Biology, vol.160(6): 909–918, http://dx.doi.org/10.1083/jcb.200212064.
12. Zuk P, Zhu M, Mizuno H, et al. 2001, Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies. Tissue Engineering, vol.7(2): 211–228, http://dx.doi.org/10.1089/107632701300062859.
13. Parolini O, Alviano F, Bagnara G P, et al. 2008, Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells, vol.26(2): 300–311, http://dx.doi.org/10.1634/stemcells.2007-0594.
14. Erices A, Conget P and Minguell J J, 2000, Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology, vol.109(1): 235–242, http://dx.doi.org/10.1046/j.1365-2141.2000.01986.x.
15. Zvaifler N J, Marinova-Mutafchieva L, Adams G, et al. 2000, Mesenchymal precursor cells in the blood of normal individuals, Arthritis Research, vol.2: 477–488, http://dx.doi.org/10.1186/ar130.
16. Miura M, Gronthos S and Zhao M 2003, Stem cells from human exfoliated deciduous teeth. Proceeding of the National Academy of Sciences of the United States of America, vol.100(10): 5807–5812, http://dx.doi.org/10.1073/pnas.0937635100.
17. Toma J, McKenzie I, Bagli D, et al. 2005, Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells, vol.23(6): 727–737, http://dx.doi.org/10.1634/stemcells.2004-0134.
18. Song L, Young N J and Webb N E, 2005, Origin and characterization of multipotential mesenchymal stem cells derived from adult trabecular bone. Stem Cells Development, vol.14(6): 712–721, http://dx.doi.org/10.1089/scd.2005.14.712.
19. Dominici M, Le blanc K, Mueller I, et al. 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, vol.8(4): 315–317, http://dx.doi.org/10.1080/14653240600855905.
20. Lazarus H, Haynesworth S, Gerson S, et al., 1995, Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplantation, vol.16(4): 557–564.
21. ClinicalTrials.gov: A service of the U.S. National Institutes of Health, n.d., viewed on November 8, 2015, https://clinicaltrials.gov/>.
22. Tseng S S, Lee M A and Reddi A H, 2008, Nonunions and the potential of stem cells in fracture-healing. The Journal of Bone and Joint Surgery, vol.90 (Suppl 1): 92–98, http://dx.doi.org/10.2106/JBJS.G.01192.
23. Gómez-Barrena E, Rosset P, Lozano D, et al. 2015, Bone fracture healing: Cell therapy in delayed unions and nonunions. Bone, vol.70: 93–101, http://dx.doi.org/10.1016/j.bone.2014.07.033.
24. Pieske O, Wittmann A, Zaspel J, et al. 2009, Autologous bone graft versus demineralized bone matrix in internal fixation of ununited long bones. Journal of Trauma Management & Outcomes, vol.3: 11, http://dx.doi.org/10.1186/1752-2897-3-11.
25. Sen M K and Miclau T, 2007, Autologous iliac crest bone graft: Should it still be the gold standard for treating nonunions? Injury, vol.38(1): S75–S80, http://dx.doi.org/10.1016/j.injury.2007.02.012.
26. Hernigou P, Beaujean F. Abnormalities in the bone marrow of the iliac crest in patients Who Have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. The Journal of Bone & Joint Surgery, 1997, 79(7): 1047–1053.
27. Hauzeur J P, Gangji V. Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells International, 2010, 2010: 410170.
28. Mathieu M, Rigutto S, Ingels A, et al. Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone, 2013, 53(2): 391–398.
29. Mendicino M, Bailey A M, Wonnacott K, et al. MSC-based product characterization for clinical trials: An FDA perspective. Cell Stem Cell, 2014, 14(2): 141–145.
30. Roemeling-van Rhijn M, Khairoun M, Korevaar S S, et al. Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive in vitro and in a humanized allograft rejection model. Journal of Stem Cell Research & Therapy, Suppl 6(1): 20780.
31. Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells and Development, 2012, 21(14): 2724–2752.
32. Bourin P, Bunnell B A, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy, 2013, 15(6): 641–648.
33. Bochev I, Elmadjian G, Kyurkchiev D, et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biology International, 2008, 32(4): 384–393.
34. De Ugarte D A, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs, 2003, 174: 101–109.
35. De Ugarte D A, Alfonso Z, Zuk P A, et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunology Letters, 2003, 89(2–3): 267–270.
36. Sakaguchi Y, Sekiya I, Yagishita Y, et al. Comparison of Human Stem Cells Derived From Various Mesenchymal Tissues. Arthritis & Rheumatism, vol.52(8): 2521–2529.
37. Chen H T, Lee M J, Chen C H, et al. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. Journal of Cellular and Molecular Medicine, 2012, 16(3): 582–592.
38. Dmitrieva R I, Minullina I R, Bilibina A A, et al. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle, 2012, 11(2): 377–383.
39. Pachón-Peña G, Yu G, Tucker A, et al. Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. Journal of Cellular Physiology, 2011, 226(3): 843–851.
40. Amable P R, Teixeira M V, Carias R B, et al. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Research & Therapy, 2014, 5(2): 53.
41. Zhu X, Shi W, Tai W, et al. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells. Cell Tissue Research, 2012, 350(2): 277–287.
42. Brocher J, Janicki P, Voltz P, et al. Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone-marrow: rescue by chondrogenic pre-induction. Stem Cell Research, 2013, 11(3): 1393–1406.
43. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental Hematology, 2005, 33(11): 1402–1416.
44. Vishnubalaji R, Al-Nbaheen M, Kadalmani B, et al. Comparative investigation of the differentiation capability of bone-marrow and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis. Cell & Tissue Research, 2012, 347(2): 419–427.
45. Im G I, Shin Y W, Lee K B. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage, 2005, 13(10): 845–853.
46. Jin H J, Bae Y K, Kim M, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. International Journal of Molecular Sciences, 2013, 14(9): 17986–18001.
47. Reinisch A, Etchart N, Thomas D, et al. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood, 2015, 125(2): 249–260.
48. Najar M, Raicevic G, Boufker H I, et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cellular Immunology, 2010, 264(2): 171–179.
49. Niemeyer P, Kornacker M, Mehlhorn A, et al. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Engineering, 2007, 13(1): 111–121.
50. Zhang Z Y, Teoh S H, Chong M S, et al. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells, 2009, 27(1): 126–137.
51. Jo C H, Yoon P W, Kim H, et al. Comparative evaluation of in vivo osteogenic differentiation of fetal and adult mesenchymal stem cell in rat critical-sized femoral defect model. Cell Tissue Research, 2013, 353(1): 41–52.
52. Hattori H, Masuoka K, Sato M, et al. Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. Journal of Biomedical Materials Research Part B: Applied Biomaterials,vol.76B(1):230–239.
53. Wen Y, Jiang B, Cui J, et al. Superior osteogenic capacity of different mesenchymal stem cells for bone tissue engineering. Oral Surgery Oral Medicine Oral Pathology Oral Radiology, 2013, 116(5): e324–e332.
54. Hayashi O, Katsube Y, Hirose M, et al. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcified Tissue International, 2008, 82: 238–247.
55. Lin L, Shen Q, Wei X, et al. Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects. Calcified Tissue International, 2009, 85(1): 55–65.
56. Kang B J, Ryu H H, Park S S, et al. Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton’s jelly for treating bone defects. Journal of Veterinary Science, 2012, 13(3): 299–310.
57. Stockmann P, Park J, von Wilmowsky C, et al. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells: a comparison of different tissue sources. Journal of Cranio-maxillo-facial Surgery, 2012, 40(4): 310–320.
58. Niemeyer P, Fechner K, Milz S, et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials, 2010, 31(13): 3572–3579.
59. Abdallah B M, Kassem M. Human mesenchymal stem cells: From basic biology to clinical applications. Gene Therapy, 2008, 15(2): 109–116.
60. Ullah I, Subbarao R B, Rho G J. Human mesenchymal stem cells - current trends and future prospective. Bioscience Reports, 2015, 35(2) pii: e00191.
61. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 2006, 24(5): 1294–1301.
62. Mosna F, Sensebé L, Krampera M. Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Development, 2010, 19(10): 1449–1470.
63. Hass R, Kasper C, Böhm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication & Signaling, 2011, 9: 12.
64. Li J, Wong W H, Chan S, et al. Factors affecting mesenchymal stromal cells yield from bone marrow aspiration. Chinese Journal of Cancer Research, 2011, 23(1): 43–48.
65. Fekete N, Rojewski MT, Fürst D, et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One, 2012, 7(8): e43255.
66. Ramakrishnan A, Torok-Storb B, Pillai M M. Primary marrow-derived stromal cells: isolation and manipulation. Methods in Molecular Biology, 2013, 1035: 75–101.
67. Rada T, Reis R L, Gomes ME. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Engineering Part B Reviews, 2009, 15(2): 113–125.
68. Gimble J M, Katz A J, Bunnell B A. Adipose-derived stem cells for regenerative medicine, Circulation Research, 2007, 100(9): 1249–1260.
69. Locke M, Windsor J, Dunbar P R. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ Journal of Surgery, 2009, 79(4): 235–244.
70. Bunnell B A, Flaat M, Gagliardi C, et al. Adipose-derived stem cells: Isolation, expansion and differentiation. Methods,vol.45(2): 115–120.
71. Aust L, Devlin B, Foster S J, et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy, 2004, 6(1): 7–14.
72. Zhu Y, Liu T, Song K, et al. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochemistry and Function, 2008, 26(6): 664–675.
73. Liao H T, Chen C T. Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells. World Journal of Stem Cells, 2014, 6(3): 288–295.
74. Li Y, Charif N, Mainard D, et al. Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity. Bio-medical Material and Engineering, 2014, 24(Suppl 1): 47–52.
75. Li C Y, Wu X Y, Tong J B, et al. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Research & Therapy, 2015, 6: 55.
76. Gronthos S, Franklin D M, Leddy H A, et al. Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology, 2001, 189(1): 54–63.
77. Festy F, Hoareau L, Bes-Houtmann S, et al. Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes. Histochemistry Cell Biology, 2005, 124(2): 113–121.
78. Mitchell J B, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 2006, 24(2): 376–385.
79. Suga H, Matsumoto D, Eto H, et al. Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Development, 2009, 18(8): 1201–1210.
80. Maumus M, Peyrafitte J A, D'Angelo R, et al. Native human adipose stromal cells: localization, morphology and phenotype. International Journal of Obesity, 2011, 35(9): 1141–1153.
81. Noël D, Caton D, Roche S, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Experimental Cell Research, 2008, 314(7): 1575–1584.
82. Krebsbach P H, Kuznetsov SA, Satomura K, et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation, 1997, 63(8): 1059–1069.
83. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 2007, 131(2): 324–336.
84. Kasten P, Vogel J, Luginbuhl R, et al. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials, 2005, 26(29): 5879–5889.
85. Mankani M H, Kuznetsov S A, Wolfe R M, et al. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells, 2006, 24(9): 2140–2149.
86. Janicki P, Boeuf S, Steck E, et al. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Cells and Materials, 2011, 21: 488–507.
87. Yang M, Ma Q J, Dang G T, et al. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7. Cytotherapy, 2005, 7: 273-281.
88. Hao W, Hu Y Y, Wei Y Y, et al. Collagen I gel can facilitate homogenous bone formation of adipose-der
ived stem cells in PLGA-beta-TCP scaffold. Cells Tissues Organs, vol.187(2):89–102.
89. Lin Y, Wang T, Wu L, et al. Ectopic and in situ bone formation of adipose tissue-derived stromal cells in biphasic calcium phosphate nanocomposite. Journal of Biomedical Materials Research Part A, 2007, 81A(4): 900–910.
90. Lee S J, Kang S W, Do H J, et al. Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. Biomaterials, 2010, 31: 5652–5659.
91. Carano R A, Filvaroff E H. Angiogenesis and bone repair. Drug Discovery Today, 2003, 8(21): 9809.
92. Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Archives of Biochemistry and Biophysics, 2014, 561: 109–117.